Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00308802
Status:
COMPLETED
Last Update Posted:
2013-09-02
First Post:
2006-03-28
Brief Title:
Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test noninvasive methods to monitor the health and condition of new kidneys in people who have received kidney transplants
Detailed Description:
Innovations in kidney transplantation have improved short-term outcomes for transplant patients However organ rejection remains as an important threat to the long-term survival of the transplanted organ If clinicians could better monitor the condition of the organ after transplantation they may be able to improve the chance of graft survival Noninvasive ways to monitor the condition of the transplanted organ need to be developed and tested This observational study will investigate whether certain blood and urine tests are useful in monitoring the health of transplanted kidneys
This trial will involve 14 post-transplant study visits over the course of 2 years A physical exam medication history adverse events assessment and blood and urine collection will occur at all visits Kidney biopsies will occur at study entry prior to transplantation and at Month 6 in adult participants only Protocol biopsies are optional in the pediatric substudy group Additional visits may be required if organ rejection is suspected
This trial will involve 14 post-transplant study visits over the course of 2 years A physical exam medication history adverse events assessment and blood and urine collection will occur at all visits Kidney biopsies will occur at study entry prior to transplantation and at Month 6 in adult participants only Protocol biopsies are optional in the pediatric substudy group Additional visits may be required if organ rejection is suspected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None